“The grim veil has been lifted.” Excitement, and questions, mount over Lilly’s positive Alzheimer’s drug data
Doctors, investors, and patient advocacy groups breathed a collective sigh of relief Wednesday morning after Eli Lilly broke its losing streak in its decades-long endeavor …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.